Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$319M |
| 2 |
GSK
GSK
|
+$230M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$192M |
| 4 |
Verizon
VZ
|
+$174M |
| 5 |
Mastercard
MA
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$850M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$466M |
| 5 |
Meta Platforms (Facebook)
META
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.58% |
| 2 | Technology | 5.48% |
| 3 | Financials | 4.9% |
| 4 | Energy | 3.61% |
| 5 | Consumer Discretionary | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
K
2101
PUT
DELISTED
Kellanova
K
| $2.39M | ﹤0.01% |
39,086
-43,132
| -52% | -$2.64M |
|
2102
CALL
ProShares UltraShort S&P500
SDS
$371M
| $2.39M | ﹤0.01% |
1,136
-4,170
| -79% | -$9.04M |
|
|
REMY
2103
DELISTED
REMY INTL INC NEW COMMON
REMY
| $2.38M | ﹤0.01% |
108,373
+107,560
| +13,230% | +$2.34M |
|
2104
iShares Russell 2000 Value ETF
IWN
$14.6B
| $2.38M | ﹤0.01% |
23,146
+20,904
| +932% | +$2.11M |
|
2105
PUT
Johnson Controls International
JCI
$93.7B
| $2.38M | ﹤0.01% |
45,458
-18,431
| -29% | -$937K |
|
|
KND
2106
DELISTED
Kindred Healthcare
KND
| $2.36M | ﹤0.01% |
102,751
-152,124
| -60% | -$3.09M |
|
2107
Lazard
LAZ
$4.24B
| $2.36M | ﹤0.01% |
45,442
+44,348
| +4,054% | +$2.19M |
|
2108
CALL
Vertex Pharmaceuticals
VRTX
$134B
| $2.36M | ﹤0.01% |
20,200
-452,900
| -96% | -$54.3M |
|
|
PPL
2109
CALL
PPL Corp
PPL
$26.5B
| $2.36M | ﹤0.01% |
76,766
+19,970
| +35% | +$641K |
|
2110
Green Plains
GPRE
$1.09B
| $2.36M | ﹤0.01% |
84,258
+77,950
| +1,236% | +$1.95M |
|
|
IMGN
2111
DELISTED
Immunogen Inc
IMGN
| $2.35M | ﹤0.01% |
294,510
+128,294
| +77% | +$929K |
|
2112
CALL
Invesco
IVZ
$13.8B
| $2.35M | ﹤0.01% |
60,300
+1,600
| +3% | +$62.5K |
|
2113
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $2.35M | ﹤0.01% |
58,800
-41,700
| -41% | -$1.7M |
|
|
BRCD
2114
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $2.35M | ﹤0.01% |
213,700
+50,918
| +31% | +$607K |
|
2115
PUT
Canadian Natural Resources
CNQ
$98.1B
| $2.35M | ﹤0.01% |
161,967
-74,468
| -31% | -$1.07M |
|
|
AVP
2116
DELISTED
Avon Products, Inc.
AVP
| $2.35M | ﹤0.01% |
335,458
-450,400
| -57% | -$3.74M |
|
|
BKS
2117
PUT
DELISTED
Barnes & Noble
BKS
| $2.35M | ﹤0.01% |
155,805
-43,033
| -22% | -$675K |
|
|
K
2118
CALL
DELISTED
Kellanova
K
| $2.35M | ﹤0.01% |
38,447
-48,883
| -56% | -$2.99M |
|
|
DNKN
2119
CALL
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $2.34M | ﹤0.01% |
49,800
-107,000
| -68% | -$4.97M |
|
2120
Alerian MLP ETF
AMLP
$13.3B
| $2.33M | ﹤0.01% |
29,193
-7,207
| -20% | -$609K |
|
|
MVNR
2121
DELISTED
MAVENIR SYS INC COM STK (DE)
MVNR
| $2.33M | ﹤0.01% |
137,354
+133,595
| +3,554% | +$2.01M |
|
|
SREV
2122
DELISTED
ServiceSource International, Inc.
SREV
| $2.33M | ﹤0.01% |
777,402
+324,403
| +72% | +$1.19M |
|
2123
CALL
ProShares UltraShort Bloomberg Crude Oil
SCO
$589M
| $2.33M | ﹤0.01% |
670
-318
| -32% | -$1.09M |
|
2124
CALL
Paychex
PAYX
$43.1B
| $2.33M | ﹤0.01% |
47,500
-43,200
| -48% | -$2.1M |
|
2125
CALL
Royal Caribbean
RCL
$82.1B
| $2.33M | ﹤0.01% |
28,700
-33,500
| -54% | -$2.65M |
|
Similar funds
Barclays's Q1 2015 Portfolio in Review
As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.
- Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
- Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
- Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
- Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
- Barclays opened 330 new positions and closed 488 in Q1 2015.
- Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.
Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.